Monday

26th Sep 2016

Merck stops cancer drug supply to Greek hospitals

  • The pharmaceutical industry says it has contributed billions to crisis-hit EU countries (Photo: www.freeimages.co.uk)

German drug company Merck has halted life-saving cancer drug shipments to Greek public hospitals.

Its chief financial officer, Matthias Zachert told German paper Boersen-Zeitung on Saturday (3 November) that the crisis-struck country has not paid its bills.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

"It only affects Greece, where we have been faced with many problems. It's just the one product," he said.

Reuters reports that the cancer-fighting drug is called Erbitux. While the medication will no longer be available at public hospitals, Greeks can still purchase it directly from pharmacies.

The drug fights colorectal cancer and head and neck cancer and is Merck's second best-selling product. In 2011, it generated some €855 million in profits.

The Merck Group reported total revenue €2.8 billion in the second quarter of 2012, an 11.6 percent increase on quarter two last year.

An report in August by GlobalData, a market intelligence analysis group, said that pharmacies in Greece have dropped prices so that cash-strapped citizens can pay for them.

It added that the cheaper drugs have created a "lucrative export carry trade" for Greeks re-selling them over the border.

For its part, the European Federation of Pharmaceutical Industries (Efpia), a Brussels-based trade body, on Sunday sent a letter to the Greek government with a plan to maintain drug supplies in light of its near-empty state coffers.

Efpia's text - seen by Reuters - says international drug companies would be willing to ship supplies to Greece if the government caps outpatient pharmaceutical expenditure at €2.9 billion in 2012.

The news agency says Efpia wants the Greek government to pay off its overdue bills and maintain a balanced sheet.

"Setting a growth cap or budget ceiling is not something we have ever liked to do in the past, but in the current environment it is better to do that and have some stability," Richard Bergstrom, Efpia's director general, told Reuters.

Efpia says Europe's pharmaceutical industry has contributed some €7 billion in the form of rebates and discounts between 2010 and 2011 to Greece, Ireland, Italy, Portugal and Spain.

The figure represents around 8 percent of the industry's annual turnover in those markets.

Stakeholders' Highlights

  1. EFAMessages of Hope From the Basque Country and Galicia
  2. Access NowDigital Rights Heroes and Villains. See Who Protects Your Rights, Who Wants to Take Them Away
  3. Martens CentreQuo Vadis Georgia? What to Expect From the Parliamentary Elections. Debate on 29 September
  4. EJCAppalled by Recommendation to Remove Hamas From EU Terrorism Watch List
  5. GoogleBringing Education to Refugees in Lebanon With the Clooney Foundation for Justice
  6. HuaweiAn Industry-leading ICT Solution Provider and Building a Better World
  7. World VisionUN Refugees Meeting a Wasted Opportunity to Improve the Lives of Millions of Children
  8. Belgrade Security ForumCan Democracy Survive Global Disorder?
  9. YouthProAktivEntrepreneurship, Proactivity, Innovation - Turn Ideas Into Action #IPS2016
  10. GoogleTrimming the Waste-Line: Weaving Circular Economy Principles Into Our Operations
  11. Crowdsourcing Week EuropeDon't Miss the Mega Conference to Master Crowdsourcing, Crowdfunding and Innovation! 10% Discount Code CSWEU16
  12. ACCAKaras Report on Access to Finance for SMEs in a Capital Markets Union

Latest News

  1. VW website to inform European consumers about cheating
  2. Barroso had deeper ties to Goldman Sachs
  3. Hungarians to rebel against EU migrant quotas
  4. Turkey has stopped me from going home, says Erdogan critic
  5. Climate change and migration vote on the Agenda This WEEK
  6. Irish and Polish people march for abortion
  7. EU admits 'unrealistic' to close TTIP deal this year
  8. LGBT rights at stake in Georgia election